SEARCH

SEARCH BY CITATION

Keywords:

  • interferon-α;
  • restless legs syndrome;
  • movement disorder

Abstract

A patient developed restless legs symptoms paralleling the course of interferon-α (IFNα) therapy for chronic hepatitis C. Symptoms began during a course of IFNα, resolved with its suspension, and recurred on rechallenge. Restless legs syndrome may thus be an adverse effect of IFNα treatment. © 2004 Movement Disorder Society